As a result of the decision, Shilpa will not be eligible to receive FDA approval for its lenvatinib mesylate generic until February 2036.

The fourth round of job cuts this year at global drugmaker Eisai‘s U.S. corporate headquarters will take effect on May 30. The oncology and neurology pharmaceutical company from Japan announced ...

Following the nod in the EU, BIIB & Eisai's Leqembi becomes the first therapy to slow the progression of early Alzheimer's disease in the region.

The New Jersey employees being let go are all based at Eisai’s U.S. headquarters at the ON3 campus in Nutley and Clifton. The property, along Route 3, previously housed pharmaceutical giant ...

Eisai Inc. announced today that screening for Study E2086-A001-101 (Study 101) to assess the efficacy, safety and tolerability of E2086, a novel selective orexin-2 receptor, is now registered on ...

RecoMed secures funding from Eisai, enhancing digital healthcare access in South Africa, and prioritising investment in oncology, neurology, and breast-cancer care ...

Even with a full FDA approval, Eisai and Biogen’s latest Alzheimer’s disease med Leqembi appears to be moving slower than expected.

An injected version of Eisai and Biogen's Alzheimer's drug Leqembi works as well as the current intravenous version at removing toxic brain plaques, according to an analysis presented by Eisai on ...

TOKYO -- Japanese pharmaceutical company Eisai plans to further develop lecanemab, the Alzheimer's disease drug that has been approved in the U.S. for intravenous administration, so that it can be ...

Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. operations and global head of its Alzheimer’s disease unit, will retire at the end of the month.

Pharmaceutical company Eisai has disclosed it suffered a ransomware incident that impacted its operations, admitting that attackers encrypted some of its servers.

An Alzheimer’s drug from Biogen and Eisai has received accelerated approval from the Food and Drug Administration, the companies and agency announced Friday.